Woburn, MA, United States of America

Mark Hyman


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Hyman: Innovator in Biocompatible Coatings

Introduction

Mark Hyman is an accomplished inventor based in Woburn, MA (US). He holds a patent that showcases his innovative approach to biocompatible coatings, particularly in the field of antimicrobial applications. His work has significant implications for various industries, including medical and environmental technologies.

Latest Patents

Mark Hyman's notable patent is titled "Bi-laminar, hyaluronan coatings with silver-based anti-microbial properties." This invention involves a surface that features a coating comprising a base coat firmly adhered to the surface and a hydrophilic, biocompatible top-coat. The coating incorporates an antibiotic ceramic component, which is dispersed in one or both of the base coat and top-coat. In a preferred embodiment, the ceramic component is a zeolite with silver ions exchanged onto internal acidic sites of the zeolite. The top-coat includes a polysaccharide, such as hyaluronan, which enhances the coating's biocompatibility. The zeolite effectively imparts antimicrobial properties to the coating, making it a valuable innovation.

Career Highlights

Throughout his career, Mark Hyman has worked with several prominent companies, including Biocoat, Inc. and Agion Technologies LLC. His experience in these organizations has contributed to his expertise in developing advanced materials and coatings.

Collaborations

Mark has collaborated with notable professionals in his field, including Jeffrey A. Trogolo and James B. Johnston. These collaborations have likely enriched his work and expanded the impact of his innovations.

Conclusion

Mark Hyman's contributions to the field of biocompatible coatings demonstrate his commitment to innovation and excellence. His patented technology has the potential to revolutionize antimicrobial applications across various sectors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…